Retour
Fourchette du Jour
18,91 €
19,50 €
Fourchette 52 Semaines
17,86 €
29,62 €
Volume
443 257
Moyenne 50J / 200J
22,25 €
/
24,03 €
Clôture Précédente
18,85 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -76,3 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | -3,4 | 3,7 |
| Net Margin % | -12,6 | 3,9 |
| Rev Growth 5Y % | -5,2 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
33,00 €
+72.1%
Low: 32,00 €
High: 34,00 €
P/E Prévisionnel
129,7
BPA Prévisionnel
0,15 €
Croissance BPA (est.)
+0,0%
CA Est.
110 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,81 €
1,77 € – 1,85 €
|
240 M | 1 |
| FY2029 |
1,31 €
1,28 € – 1,34 €
|
200 M | 1 |
| FY2028 |
0,88 €
0,86 € – 0,90 €
|
170 M | 1 |
Points Clés
Revenue declined -5,21% annually over 5 years
Debt/Equity of 0,05 — conservative balance sheet
Generating 10,64M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 22,18%
Capital efficient — spends only 9,85% of revenue on capex
Croissance
Revenue Growth (5Y)
-5,21%
Revenue (1Y)16,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-3,37%
ROIC-2,33%
Net Margin-12,61%
Op. Margin-12,61%
Sécurité
Debt / Equity
0,05
Current Ratio5,23
Interest Coverage-4,48
Valorisation
P/E Ratio
-76,33
P/B Ratio2,49
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,97% | Revenue Growth (3Y) | 12,62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5,21% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 96,21M | Net Income (TTM) | -12,13M |
| ROE | -3,37% | ROA | -2,99% |
| Gross Margin | 64,56% | Operating Margin | -12,61% |
| Net Margin | -12,61% | Free Cash Flow (TTM) | 10,64M |
| ROIC | -2,33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 5,23 |
| Interest Coverage | -4,48 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -76,33 | P/B Ratio | 2,49 |
| P/S Ratio | 9,62 | PEG Ratio | 2,20 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 925,91M | Enterprise Value | 910,77M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 96,21M | 82,25M | 75,86M | 76,24M | 119,16M |
| Net Income | -12,13M | -20,18M | -66,43M | -139,81M | -8,91M |
| EPS (Diluted) | -0,25 | -0,44 | -1,52 | -3,29 | -0,23 |
| Gross Profit | 62,12M | 53,67M | 46,75M | 46,91M | 28,85M |
| Operating Income | -12,13M | -7,13M | -23,44M | -5,92M | -35,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 405,88M | 399,49M | 412,71M | 450,23M | 552,60M |
| Total Liabilities | 34,00M | 50,58M | 75,05M | 86,04M | 76,24M |
| Shareholders' Equity | 371,89M | 348,91M | 337,66M | 364,19M | 480,75M |
| Total Debt | 17,90M | 30,17M | 33,83M | 43,71M | 26,88M |
| Cash & Equivalents | 33,04M | 95,39M | 27,90M | 19,44M | 69,87M |
| Current Assets | 120,18M | 148,76M | 120,60M | 138,45M | 125,86M |
| Current Liabilities | 22,98M | 32,73M | 42,18M | 44,58M | 42,70M |